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Quality of life:
what does it mean for general practice?
There is no doubt that maintenance or
improvement of health-related or disease-
related quality of life (QoL) is the ultimate
goal of general practice. When keeping
this in mind it focuses practice not only on
the physical aspects of disease, but also
on how patients perceive their illnesses.
Defining general practice as
‘comprehensive personal care’1 implies
that therapies should be balanced
between evidence and patient
preferences, which are influenced by their
present and anticipated future QoL. This
is especially relevant in treating chronic
and palliative patients, when shared
decisions should be made about surgery,
medication and pain relief, withholding of
treatment, and even some forms of
euthanasia.
In the last few decades many studies
have examined the concept of QoL and
methods to gain a clear view of this
aspect of history-taking. Symptoms only
partially reflect the perceived burden of
the disease. Ferrans2 showed that in
patients with cancer, QoL instruments
provide additional information about side
effects and the impact on other aspects of
life that cannot be captured by measures
targeted at key symptoms.
There is a considerable discrepancy
between patients’ assessment of their
own health and their doctor’s
judgement.3,4,5,6 So it is vital for GPs to ask
questions about the commonly
distinguished QoL domains of physical,
mental, social, and psychological
consequences of disease. Instruments to
overcome bias in the perceptions of
healthcare providers might be helpful in
determining QoL. The content, the
phrasing, and ways of administering of
the instruments is the subject of many
studies validating generic or disease-
specific instruments. Generic instruments
(such as the SF-36,7 EQ-5D,8 SF-6D,9
WHOQOL-100,10 Sickness Impact
Profile,11 Nottingham Health Profile,12 and
the COOP/WONCA13 charts) and disease-
specific instruments have to meet criteria
for validity, reliability, sensitivity to
change, and applicability.14
Recent reviews have emphasised the
difficulties of choosing between the large
number of QoL instruments available. For
instance, one study on QoL instruments
for children and adolescents found 30
generic and 64 disease-specific
instruments.15 Great efforts have been
made to cross-validate QoL instruments
for various diseases, nationalities,
cultures, and target populations.
Often researchers are advised to use a
generic as well as a disease-specific
instrument to cover all methodological
criteria. But for integration in daily
practice the key issue is measuring QoL in
a way that provides relevant information
for patients’ and practitioners’ decision-
making; focuses the practitioners’
attention on the patients’ concerns; and is
easy to administer during routine care.
Major questions to ask are whether we
can use these instruments in clinical
practice and for (economic) decisions in
the area of public health.
In the present issue of the BJGP two
studies are published from the Respiratory
Research Group in Manchester.16,17 Both
studies are based on postal surveys
carried out in the registered population of
two general practices. The surveys
included the EQ-5D: a generic QoL
instrument covering the five dimensions of
mobility, self-care, usual activities,
pain/discomfort, and anxiety/depression,
from which an index score is calculated. In
the first study16 a cross-sectional analysis
showed how comorbidity affects the EQ-
5D index. In the second study17 the
changes in the EQ-5D scores were
calculated for patients who had three
consecutive measurements over a 5-year
period. The researchers found that QoL
decreases with increasing numbers of
chronic conditions, and that in a cohort of
about 2500 participants the quality of life
declined significantly over 5 years after
adjusting for age, education level and
duration, sex, and smoking behaviour.
Although the studies were performed
5 years ago and were locally restricted,
these results may have implications for
clinical practice and public health in
general.
The various QoL measures can be used
for research purposes, economic decision
making, and for decision making in
clinical practice, but need to be tailored to
these goals.15
In clinical practice QoL measures are
currently used for needs assessment and
monitoring purposes. Chronic disease
management systems, with the aim of
delivering systematic multidisciplinary
care that is also targeted at individual
needs, often incorporate disease-specific
instruments to assess needs and/or to
monitor changes in perceived disease
consequences.
Older patients are often included in
several disease management systems
because they have more than one chronic
condition. They often have to complete
several QoL instruments thus increasing
the ‘load of care’ for themselves and the
burden for the health professionals. The
use of one generic instrument, like the
EQ-5D which shows a decrease in QoL
with an increase in number of diseases,
may reduce this load. This presents a
dilemma, as generic instruments provide
less information on the perceived effects
of particular conditions than disease-
specific ones, and specific instruments
are more responsive to changes in
disease conditions than the
corresponding domains of generic
instruments.18
For clinical practice, QoL measures
should be easily incorporated into the
daily routine. Different ways of
administering tests (interview or
questionnaire, by telephone or computer,
the frequency and time intervals of
administering) affect patient scores, as
does the type of questioning. To illustrate
how type of questioning can have an
impact patient scores, a study on patients
with HIV1 infection showed that they
evaluated their QoL significantly worse
when the questioning was retrospective
compared to prospective, and that the
retrospective scores showed better
associations with change in clinical
indicators than the prospective
questioning.16
QoL instruments are also needed as
outcome indicators to calculate quality-
adjusted life years and cost-effectiveness
of therapy and care-delivery interventions.
The study by Hazell et al showed17 an
autonomous decrease in QoL over a 5-
year period, indicating the difficulty of
taking a point of reference. Questions
arise around the validity of health-related
QoL measures; for example, which
cultural and economic influences interfere
with health related QoL? These questions
around validity and reliability gain
prominence when QoL measurements are
used as patient outcome parameters in
quality assessment and pay-for-
performance systems.
Although much focus is put on hard
clinical outcome measures like reducing
blood pressure or HbA1c, it is
understandable that those responsible for
public finances and for safe and effective
health care are looking for measures
related to the ultimate goal of care. But a
rule of thumb should be that performance
indicators are related to those aspects of
care delivery that can be controlled and
changed by healthcare professionals.19 It
is a challenge for research and practice to
find ways and instruments to base quality
assessments on how patients evaluate
their quality of life related to the care that
they received.
A key issue for general practice is taking
into account patients’ needs and
preferences and the context of the patient.
Health professionals’ views often differ
from patients’ perceptions. GPs differ in
their routine questioning. The systematic
incorporation of QoL measures in
consultations may be helpful to get a
clearer picture of how patients perceive
their health-related QoL and its course.
QoL measures can also be helpful as a
stimulus for practice improvement when
used as patient outcomes in quality
assessment procedures. The use of QoL
measures as indicators in pay-for-
performance systems is unlikely in the
near future; still, it is a challenge for
research and clinical practice to find ways
to increase patient centredness by using
QoL instruments in general practice.
JE Jacobs,
Senior Researcher, Department of IQ
Healthcare, Radboud University Medical Centre
Nijmegen, The Netherlands.
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